Miguel Ángel TempranoEconomics, geopolitics and investment
ES·EN

Salud

12 May 2022

Growth, stagflation or recession

Covid is not over and stability has not arrived. Three scenarios on the table, and governments acting as if only the good one existed.

25 Feb 2021

The new “value”: The Biotecnology

ESG is spoken of as the megatrend of the present, but caring for the environment, the E of the acronym ESG, is more than a trend, it is…

10 Feb 2021

MK7110. The reason for an investment idea

We are very excited, even euphoric about the arrival of the vaccine, but it is not enough, an effective medical treatment is needed for the advanced stages of…

27 Jan 2021

Waiting for the real solution. The treatment

A vaccine within eight months is an unprecedented achievement. Manufacturing and distributing it is the biggest challenge, and the fundamental solution remains treatment.

31 Jul 2020

Vaccine vs. Medicine. What is more urgent?

We live with constant announcements about advances in the manufacture of the long-awaited vaccine. More than 154 teams research worldwide in a research operation never seen before, but…

Get every column by email

You will be told whenever something new is published: a column, an analysis or a research note. No advertising, and your details are never passed on.

One click to unsubscribe in every email.